Novato, California Monday, July 14, 2025, 16:00 Hrs [IST] ...

The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...

The specific parameters defined in your label, including patient population, line of therapy, and outcomes measured, will now ...

Takeda is on track to submit its much-hyped narcolepsy drug to regulators this fiscal year after the orexin receptor 2 (OX2R)-selective agonist ...

Imugene Limited (ASX: IMU), a clinical-stage immuno-oncology company, is pleased to announce exciting new data from its Phase 1b clinical trial evaluating azer-cel (azercabtagene zapreleucel) in ...

FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.

Atrioventricular interval modulation is being studied for patients with uncontrolled hypertension. Could the new technology ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

The Maharashtra FDA has suspended the licence of Pune's renowned Cafe Goodluck due to hygiene issues. This action followed a ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.